−£1.77m
vs Dec 2023Active13152498Private limited companyLondon
75PHARMA GROUP LIMITED
Significant control: Pasi Petteri Ruokostenpohja (25–50%), Niko Johannes Nevala (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for 75pharma Group Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does 75pharma Group Limited sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
75PHARMA GROUP LIMITED is an active private limited company (company number 13152498) incorporated on 22 January 2021, registered in London. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 31 December 2024, showing net assets of −£1.77m and cash of £1,278, with 1 employee on average. Net assets fell 1266% on the prior period (−£130k).
Peer position · net assets
By net assets it sits in the bottom quarter of 76 comparable companies in London (median £100, upper quartile £88k).
02
Ownership and control
- Mr Pasi Petteri Ruokostenpohja
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Niko Johannes Nevala
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Tony Ivan Sorensen
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 22 January 20215 yrs ago
- Next accounts due
- 30 September 202625 days overdue
- Confirmation statement due
- 5 February 2027in 103 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 64209
- Activities of other holding companies n.e.c.
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£1,278
−30%vs Dec 2023Not reported
1
No changevs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£1.77m | £1,278 | £425k | — | — | — | 1 |
| 31 December 2023 | −£130k | £1,828 | £229k | — | — | — | 1 |
Cash per employee£1,278Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-1,773,165 at 31 December 2024
- Net assets down 25% or more on the prior period-1266.4% vs prior period
- Incorporated five or more years agoIncorporated 22 January 2021
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 103 days
- Next accounts due25 days overdue
- Accounts period endNet liabilities £1.77m · small accounts
- Accounts period endNet liabilities £130k · small accounts
- Incorporated
08
Similar companies in London
- BIONTECH UK LIMITEDLondon · inc. Nov 2020
- MAITRI ARTHA SHASTRA LIMITEDLondon · inc. Nov 2020
- MEDCANN PHARMA LTDLondon · inc. May 2021
- CONSERV BIOSCIENCE LIMITEDLondon · inc. Oct 2020
- TRIRX SPEKE LTDLondon · inc. Jun 2021
- STARK PHARMACEUTICALS LIMITEDLondon · inc. Aug 2020
All companies incorporated on 22 January 2021 · in Jan 2021.
09
Reminders for 75PHARMA GROUP LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.